Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Maze Therapeutics Inc (MAZE)

Maze Therapeutics Inc (MAZE)
11.42 +0.15 (+1.33%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Fri, Mar 28th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
10.93
Day High
11.64
Open 11.22
Previous Close 11.27 11.27
Volume 68,500 68,500
Avg Vol 262,890 262,890
Stochastic %K 40.59% 40.59%
Weighted Alpha N/A N/A
5-Day Change +0.28 (+2.51%) +0.28 (+2.51%)
52-Week Range 9.88 - 17.00 9.88 - 17.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 499,933
  • Shares Outstanding, K 43,777
  • Annual Sales, $ 0 K
  • Annual Income, $ -100,415 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 2.98
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on 01/31/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -7.60
  • Number of Estimates 1
  • High Estimate -7.60
  • Low Estimate -7.60
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.88 +15.59%
on 03/17/25
Period Open: 12.23
13.04 -12.42%
on 03/07/25
-0.81 (-6.62%)
since 02/28/25

Business Summary

Maze Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases. Maze Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif....

See More

Key Turning Points

3rd Resistance Point 12.44
2nd Resistance Point 12.04
1st Resistance Point 11.73
Last Price 11.42
1st Support Level 11.02
2nd Support Level 10.62
3rd Support Level 10.31

See More

52-Week High 17.00
Fibonacci 61.8% 14.28
Fibonacci 50% 13.44
Fibonacci 38.2% 12.60
Last Price 11.42
52-Week Low 9.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies